Baxter And TAU Ink New Licensing Agreements Through Ramot
Zacks Investment Research | Jul 07, 2017 08:56AM ET
A global medical products company Baxter International Inc. (NYSE:BAX) is consistently making efforts to expand its surgical care business. In line with this, the company has recently teamed up with Tel Aviv University, Israel's largest research and teaching university (TAU), on two new licensing agreements through Ramot. Notably, Ramot is the Business Engagement Center at Tel Aviv University.
The tie-up includes joint research efforts to evaluate multiple technologies that are currently under development at the university as well as Tel Aviv Sourasky Medical Center (TASMC). TASMC is one of the largest academic medical centers, affiliated with the Faculty of Medicine at TAU, providing the most progressive full-service healthcare treatment and research institutions in Israel.
Baxter will be working closely with TAU and TASMC to commercialize early-stage research and introduce latest innovations in surgical care. Per the press release, “Baxter will exclusively license the TAU Technology Innovation Momentum Fund technology in one license agreement and TAU and TASMC technology in the second license agreement for use in multiple potential applications that might result from the joint research activity.”
Baxter, TAU and TASMC have planned to work together with the goal of exploring potential applications of multiple projects that aim to fulfil unmet needs. If these applications yield the desired results, it will reach Baxter’s portfolio of products into new areas of surgical care and complement the company's line of offerings.
Over the past three months, Baxter has been trading above the Zacks categorized Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.